Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 129 of 2459…ety signals after 9 months of follow-up.All 7 patients received A2B694, were efficacy-evaluable, and had A2B694 detected post-infusion…
…utologous TCR-T targeting PRAME in patients with PD1 refractory metastatic melanoma. Abstract 2508. Presented at: ASCO Annual Meeting; June 2025; C…
…anced solid tumors. These results support further evaluation of ASKG915.Acknowledgements We thank the patients and their families for t…
…Background For over 30 years, microbial immunotherapy with Bacillus Calmette-Guérin (BCG) has been the standard-of-care for non-muscle invasive bla…
…nine head and neck cancer (HNC).Results In mouse models of HNC, BSCgal enhances both radiodynamic and immune responses of SABR. It inc…
…rtunities in cancer immunotherapy’.Results Since its inception, ImmunoSchool has trained over 7,000 participants from more than 80 countries…
…sity of Texas – Houston, and Fox Chase Cancer Center), with the University of Virginia at the lead institution; approval number: IRB-HSR #11491.Abstra…
… (IL-1β and IL-6) responses. Notably, in melanoma (B16-F10) and glioblastoma (CT-2A) in vivo models, IBDV treatment delayed tumor growth and…
…Background mCRPC is an advanced disease stage where, regardless of testosterone-…
… Evaluating Respiratory Symptoms in COPD (E-RS:COPD).Results In dupilumab recipients, moderate or severe exacerbations were reduced by 22…
…onsistent with the phenotype of aberrant basaloid cells seen in IPF. We propose that extrusion of small airway epithelial cells may…